FDA Recall of Philips Respironics Trilogy Evo Ventilator
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
The FDA has issued a recall for 113,717 units of the Philips Respironics Trilogy Evo ventilator due to a potential delay in the obstruction alarm, which may not trigger as required.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 16, 2026 and geographically references United States. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.
Recall Article: Philips Respironics Trilogy Evo
What Happened
Philips Respironics, Inc. is recalling its Trilogy Evo ventilator devices because the Obstruction Alarm does not trigger within the timeframe required by standards and may take up to four breaths in some situations.
Which Products Are Affected
The affected products are the Philips Respironics Trilogy Evo with Software Version 1.05.15.00, a continuous home-use ventilator device. This recall involves 113,717 units, covering all model numbers, UDIs, and serial numbers. The products were distributed nationwide in the United States and to various foreign countries.
What You Should Do
Consumers should follow the initial firm notification, which was issued via letter. For further details, contact the recalling firm, Philips Respironics, Inc.
Why This Matters
This recall addresses a potential safety issue with a medical device used for breathing assistance, which could impact patient health if the alarm fails to activate promptly.
Source
Information from FDA recall notice, recall number Z-1646-2026.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,090 characters here).
Similar severity timing
Same severity (high) notices issued closest in time to April 16, 2026.
Frequently Asked Questions
Common questions about this FDA recall.